Сахарный диабет (Dec 2012)

Compromised calcium and phosphorus metabolism in patients with diabetes mellitus and chronic kidney disease

  • Margarita Stanislavovna Biragova,
  • Svetlana Alexandrovna Gracheva,
  • Sergey Andreevich Martynov

DOI
https://doi.org/10.14341/2072-0351-5542
Journal volume & issue
Vol. 15, no. 4
pp. 74 – 80

Abstract

Read online

Disturbance of bone and mineral metabolism (BMM) is one of manifestations of chronic kidney disease (CKD), but its significance goes beyond bone disorders per se. Current discourse is as broad as to include vascular calcification, anemia and arterial hypertension, - conditions increasing mortality in patients with CKD. In this regard the active search for and development of novel approach to correction of BMM is under way. Apart from capacity to normalize calcium and phosphorus metabolism, parathyroid hormone secretion and to reduce morphologic alterations of bone tissue, modern therapeutic agents feature cardio- and renoprotective capabilities, which make them a treatment of choice for compromised BMM in CKD.

Keywords